Link between intracellular pathogens and cardiovascular diseases

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Grepafloxacin: microbiological properties
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Atypical respiratory pathogens
Hydatid disease Clinical Microbiology and Infection
Extraction of Chlamydia pneumoniae DNA from vascular tissue for use in PCR: an evaluation of four procedures  H.F. Berg, B. Maraha, A.M.C. Bergmans, A.
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
R. Karakus, K. Caglar, C. Aybay  Clinical Microbiology and Infection 
Michael W. Carter, Timothy G. Harrison, M. Shuja Shafi, Robert C
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Sepsis and neutropenia induced by clozapine
Uncommon opportunistic fungi: new nosocomial threats
Elements of design: the knowledge on which we build
André Bryskier  Clinical Microbiology and Infection 
Geneviève Cremer, Patrick Boiron  Clinical Microbiology and Infection 
Levofloxacin in the treatment of ventilator-associated pneumonia
Evaluation of the effect of interleukin-10 on the multiplication of Mycobacterium avium complex in human macrophages and in C57BL/6 mice  Hilte F. Geerdes-Fenge,
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
A. Bryskier  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Grepafloxacin: pharmacokinetics and tissue penetration
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Training in infectious diseases and tropical medicine in Britain
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
J. R. Blanco, C. Gutierrez, M. Zabalza, J. Salcedo, I. Erdozain, J. A
Definition of the Clinical Antibacterial Spectrum of Activity
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.
Overview of cefixime use in community-acquired infections
Sanford Chodosh  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
J.L. Balcázar  Clinical Microbiology and Infection 
New patterns of HIV-1 resistance during HAART
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party  Dilip Nathwani, Christopher Conlon  Clinical.
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Link between intracellular pathogens and cardiovascular diseases Enrique Gurfinkel  Clinical Microbiology and Infection  Volume 4, Pages 4S33-4S36 (November 1998) DOI: 10.1111/j.1469-0691.1998.tb00701.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Possible modification of immunologic responses by C. pneumoniae. M, macrophage cell; IgG, antibody to Chlamydia; IL, interleukin; TF, tissue factor. Clinical Microbiology and Infection 1998 4, 4S33-4S36DOI: (10.1111/j.1469-0691.1998.tb00701.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.